| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3297397 | Gastroenterology | 2011 | 11 Pages |
Abstract
Budesonide (9 mg/day) was numerically, but not statistically, more effective than Eudragit-L-coated mesalamine (4.5 g/day) in patients with mildly to moderately active CD. Budesonide (9 mg/day), administered once daily, was as effective as the standard (3 times daily) regimen.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Andreas Tromm, Ivan BunganiÄ, Eva Tomsová, Zsolt Tulassay, Milan LukáÅ¡, Jan Kykal, Marian Bátovský, Bohumil Fixa, Libor Gabalec, Rifaat Safadi, Heinz-Jochen Kramm, István Altorjay, Hanns Löhr, Ioannis Koutroubakis, Simon Bar-Meir,